AAKAAR MEDICAL TECHNOLOGIES LIMITED
L74900MH2013PLC244717
DataDelta records 0 directors, 0 financial line items, 46 NSE events, and 0 group companies for AAKAAR MEDICAL TECHNOLOGIES LIMITED. Appointment dates and ownership percentages are withheld until they pass a data-quality check.
- ISIN
- INE1GYP01013
- NSE
- AAKAAR
- BSE
- —
- Listing
- Listed
- Status
- Active
- State
- maharashtra
- Class
- Public
- Industry
- Business Services
Events
46 shown of 46
| Date | Type | Status | Title |
|---|---|---|---|
| 2026-09-24 | TradingWindow | Announced | Aakaar Medical Technologies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 2026-07-01 | ShareholderMeeting | Completed | Aakaar Medical Technologies Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on Jun 30, 2026. Further, the company has informed the Exchange regarding voting results. |
| 2026-06-30 | ShareholderMeeting | Completed | Aakaar Medical Technologies Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on Jun 30, 2026 |
| 2026-06-30 | Disclosure | Announced | Aakaar Medical Technologies Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company. |
| 2026-06-30 | Disclosure | Announced | Aakaar Medical Technologies Limited has informed the Exchange regarding Change in Auditors of the company. |
| 2026-06-19 | FinancialResults | Completed | The Exchange had sought clarification from Aakaar Medical Technologies Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted in XBRL with discrepancies. -2. Financial results submitted is not as per format prescribed by SEBI. -3. Machine Readable Form / Legible copy of Financial Results not submitte |
| 2026-06-05 | ShareholderMeeting | Completed | Aakaar Medical Technologies Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on Jun 30, 2026 |
| 2026-05-28 | Disclosure | Announced | Aakaar Medical Technologies Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 |
| 2026-05-28 | BoardMeeting | Completed | Aakaar Medical Technologies Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. |
| 2026-05-25 | FinancialResults | Completed | The Exchange has sought clarification from Aakaar Medical Technologies Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted in XBRL with discrepancies. -2. Financial results submitted is not as per format prescribed by SEBI. -3. Machine Readable Form / Legible copy of Financial Results not submitted |
| 2026-05-25 | BoardMeeting | Completed | Aakaar Medical Technologies Limited has informed the Exchange regarding Outcome of Board Meeting held on May 25, 2026. |
| 2026-05-21 | ShareholderMeeting | Completed | Aakaar Medical Technologies Limited has informed the Exchange that Record date for the purpose of Record Date for determining shareholders entitled to receive Notice of AGM is 29-May-2026. |
| 2026-05-20 | ESOP | Announced | AAKAAR MEDICAL TECHNOLOGIES LIMITED has informed the Exchange about Board Meeting to be held on 25-May-2026 to consider and approve ESOP/Increase in authorised capital/Other business. |
| 2026-05-20 | ESOP | Announced | AAKAAR : 25-May-2026 : The Company has informed the Exchange that a Board meeting to be held on May 22, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 25, 2026, To consider and approve the ESOP Scheme and other matters |
| 2026-05-18 | ESOP | Announced | AAKAAR MEDICAL TECHNOLOGIES LIMITED has informed the Exchange about Board Meeting to be held on 22-May-2026 to consider and approve ESOP/Increase in authorised capital. |
| 2026-05-18 | ESOP | Pending | To consider and approve the proposal for introduction of Employee Stock Option Scheme ( ESOP Scheme ) and increase in the Authorised Share Capital of the Company, subject to necessary approvals. |
| 2026-05-15 | BoardMeeting | Completed | Aakaar Medical Technologies Limited announces its Outcome of the Board Meeting in accordance with the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015. |
| 2026-05-15 | Disclosure | Announced | Aakaar Medical Technologies Limited has informed the Exchange regarding a press release dated May 15, 2026, titled "Aakaar Medical Technologies Ltd. announces H2 & FY2025-26 ResultsStrongest H2 - Delivered as promised; Impact of tightened and disciplined financial approach". |
| 2026-05-15 | Disclosure | Announced | Aakaar Medical Technologies Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 |
| 2026-05-15 | Appointment | Announced | Aakaar Medical Technologies Limited has informed the Exchange regarding Appointment of as Other of the company w.e.f. May 15, 2026. |
| 2026-05-15 | Disclosure | Announced | Aakaar Medical Technologies Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 |
| 2026-05-15 | Disclosure | Announced | Aakaar Medical Technologies Limited has informed the Exchange about Arrangements for strategic, technical, manufacturing, or marketing tie up |
| 2026-05-09 | Disclosure | Announced | SDD Compliance Certificate for the year ended 31st March, 2026. |
| 2026-04-01 | FinancialResults | Completed | To consider and approve the financial results for the period ended March 31, 2026 and other business matters |
| 2026-04-01 | BoardMeeting | Completed | AAKAAR MEDICAL TECHNOLOGIES LIMITED has informed the Exchange about Board Meeting to be held on 15-May-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Other business. |
| 2026-03-28 | TradingWindow | Announced | Aakaar Medical Technologies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 2026-02-23 | Disclosure | Announced | Aakaar Medical Technologies Limited has informed the Exchange about Arrangements for strategic, technical, manufacturing, or marketing tie up |
| 2026-02-20 | Disclosure | Announced | Aakaar Medical Technologies Limited has informed the Exchange regarding a press release dated February 20, 2026, titled "Strategic Tie-Up with Tricopat". |
| 2026-02-18 | Disclosure | Announced | Aakaar Medical Technologies Limited has informed the Exchange regarding a press release dated February 18, 2026, titled "Strategic Tie-Up with FotoFinder / DermLite". |
| 2026-02-16 | Disclosure | Announced | Aakaar Medical Technologies Limited has informed the Exchange regarding a press release dated February 16, 2026, titled "XOMAGE® Plant Exosomes Registration (Korea)". |
| 2026-02-13 | Disclosure | Approved | Aakaar Medical Technologies Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "USFDA Approval of Saypha® and Marketing Advantage in India". |
| 2026-02-12 | Disclosure | Announced | Aakaar Medical Technologies Limited has informed the Exchange about Arrangements for strategic, technical, manufacturing, or marketing tie up |
| 2026-02-11 | Disclosure | Announced | Aakaar Medical Technologies Limited has informed the Exchange about VM Corporation Product launch |
| 2026-02-11 | Disclosure | Announced | Aakaar Medical Technologies Limited has informed the Exchange about Product launch |
| 2025-12-15 | BoardMeeting | Completed | Aakaar Medical Technologies Limited has informed the Exchange regarding Board meeting held on December 15, 2025. |
| 2025-12-15 | Disclosure | Announced | Aakaar Medical Technologies Limited has informed the Exchange about change in Management |
| 2025-12-02 | BoardChange | Announced | Aakaar Medical Technologies Limited has informed the Exchange regarding Resignation of Mrs. Sweta Shah as Chief Financial Officer of the company w.e.f. December 12, 2025. |
| 2025-11-10 | BoardMeeting | Completed | Aakaar Medical Technologies Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025. |
| 2025-11-10 | Disclosure | Announced | Aakaar Medical Technologies Limited has informed the Exchange regarding a press release dated November 10, 2025, titled "Aakaar Medical Technologies Ltd. announcesH1FY2025-26 Results". |
| 2025-10-31 | FinancialResults | Completed | To consider and approve the financial results for the period ended September 30, 2025 and other business matters |
| 2025-10-31 | BoardMeeting | Completed | AAKAAR MEDICAL TECHNOLOGIES LIMITED has informed the Exchange about Board Meeting to be held on 10-Nov-2025 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2025 and Other business. |
| 2025-09-25 | TradingWindow | Announced | Aakaar Medical Technologies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 2025-08-14 | Disclosure | Announced | Aakaar Medical Technologies Limited has informed the Exchange regarding a press release dated August 14, 2025, titled " Aakaar Medical Technologies to Bring Italy s VM Corporation Exosome Breakthrough to India in November 2025 ". |
| 2025-08-13 | Disclosure | Announced | Aakaar Medical Technologies Limited has informed the Exchange about Arrangements for strategic, technical, manufacturing, or marketing tie up pursuant to Regulation 30 SEBI (LODR) Regulation, 2015, read with Schedule III Part A para B clause (2) (a) |
| 2025-07-23 | Disclosure | Announced | Significant movement in price has been observed in Aakaar Medical Technologies Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Aakaar Medical Technologies Limited has submitted their response. |
| 2025-07-22 | Disclosure | Announced | Significant movement in price has been observed in Aakaar Medical Technologies Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited. |
Directors
0 shown of 0
| Name | DIN | Designation | Status |
|---|
Financials
0 shown of 0
| Year | Metric | Value | Unit |
|---|
Group companies
0 shown of 0
| Company | Relationship | Country |
|---|